These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 23128049

  • 21. Key molecular events in puromycin aminonucleoside nephrosis rats.
    Guan N, Ding J, Deng J, Zhang J, Yang J.
    Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
    [Abstract] [Full Text] [Related]

  • 22. The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
    Takeuchi S, Hiromura K, Tomioka M, Takahashi S, Sakairi T, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Nephron Exp Nephrol; 2010 Sep; 116(1):e3-10. PubMed ID: 20502051
    [Abstract] [Full Text] [Related]

  • 23. Protective effects of PPARγ agonist in acute nephrotic syndrome.
    Zuo Y, Yang HC, Potthoff SA, Najafian B, Kon V, Ma LJ, Fogo AB.
    Nephrol Dial Transplant; 2012 Jan; 27(1):174-81. PubMed ID: 21565943
    [Abstract] [Full Text] [Related]

  • 24. Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside.
    Vega-Warner V, Ransom RF, Vincent AM, Brosius FC, Smoyer WE.
    Kidney Int; 2004 Nov; 66(5):1881-9. PubMed ID: 15496159
    [Abstract] [Full Text] [Related]

  • 25. Continuous erythropoietin receptor activator (Mircera) for renal anemia.
    McGahan L.
    Issues Emerg Health Technol; 2008 Feb; (113):1-6. PubMed ID: 18354858
    [Abstract] [Full Text] [Related]

  • 26. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
    Herrmann A, Tozzo E, Funk J.
    Exp Toxicol Pathol; 2012 Jan; 64(1-2):45-9. PubMed ID: 20591637
    [Abstract] [Full Text] [Related]

  • 27. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ.
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [Abstract] [Full Text] [Related]

  • 28. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y.
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [Abstract] [Full Text] [Related]

  • 29. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
    Matsui I, Hamano T, Tomida K, Inoue K, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Kawachi H, Rakugi H, Imai E, Isaka Y.
    Nephrol Dial Transplant; 2009 Aug; 24(8):2354-61. PubMed ID: 19297354
    [Abstract] [Full Text] [Related]

  • 30. Early responsiveness to continuous erythropoietin receptor activator predicts renal prognosis and is determined by a novel antioxidative marker in non-dialysis chronic kidney disease: a prospective, observational, single-center study.
    Ino J, Kasama E, Kodama M, Harada T, Sato K, Eizumi H, Kawashima Y, Nitta K.
    Clin Exp Nephrol; 2020 Jul; 24(7):590-597. PubMed ID: 32185544
    [Abstract] [Full Text] [Related]

  • 31. [Renal expression of RANK-RANKL in a rat model of puromycin aminonucleoside nephropathy].
    Feng Z, Liu S, Shi W, Xiao H, Liang X, Liu X, Ye Z, Wang S, Liang Y, Zhang B, Wang W, Liu Y, Mei P, Xu L, Ma J, Xia Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):65-9. PubMed ID: 24463119
    [Abstract] [Full Text] [Related]

  • 32. Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
    Kawamorita Y, Shiraishi T, Tamura Y, Kumagai T, Shibata S, Fujigaki Y, Hosoyamada M, Nakagawa T, Uchida S.
    Physiol Rep; 2017 Aug; 5(15):. PubMed ID: 28774949
    [Abstract] [Full Text] [Related]

  • 33. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Aug; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 34. The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury.
    Menne J, Park JK, Shushakova N, Mengel M, Meier M, Fliser D.
    J Am Soc Nephrol; 2007 Jul; 18(7):2046-53. PubMed ID: 17554150
    [Abstract] [Full Text] [Related]

  • 35. Glomerular podocyte cell junctions in nephrotic syndrome. I. Freeze-fracture studies in rat aminonucleoside nephrosis.
    Kühn K, Sterzel RB, Reale E.
    J Submicrosc Cytol; 1981 Jul; 13(3):407-12. PubMed ID: 7334544
    [Abstract] [Full Text] [Related]

  • 36. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
    Sampaio-Maia B, Moreira-Rodrigues M, Serrão P, Pestana M.
    Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
    [Abstract] [Full Text] [Related]

  • 37. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
    Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH.
    Kidney Int; 2008 Sep; 74(5):596-612. PubMed ID: 18509322
    [Abstract] [Full Text] [Related]

  • 38. Chemical medullectomy does not prevent sodium retention in nephrotic rats.
    Keeler R.
    Miner Electrolyte Metab; 1989 Sep; 15(4):241-5. PubMed ID: 2761491
    [Abstract] [Full Text] [Related]

  • 39. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM.
    Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
    [Abstract] [Full Text] [Related]

  • 40. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H, Nakamura T, Kimura K, Ebihara I, Nagai R, Tomino Y.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.